Roswell Park Comprehensive Cancer Center

This world-class center for cancer research and treatment provides you a window into care and clinical research at the forefront of hematology and oncology.

Roswell Park exterior.

Roswell Park combines providing comprehensive cancer care with conducting vital research into cancer, with more than 120 beds and an extensive outpatient practice. Its integration of research, treatment and educational programs have met rigorous national standards and made fundamental contributions to reducing the burden of cancer. Patients visit it from all parts of Western New York and northern Pennsylvania.

The institute’s consistent success in these areas have earned it the National Cancer Institute’s designation of “comprehensive cancer center.” It is the only facility in Upstate New York to hold this honor and one of only 40 such centers in the United States.

Training

You will spend approximately one-quarter of your clinical training time here, focusing on inpatient consultations.

You will rotate with our division’s faculty and may also work with interns, residents and fourth-year medical students.

You will see patients with hematological malignancies, infections following major oncologic surgery and stem cell transplant recipients.

Our faculty also work in RPCI’s outpatient clinics, where you will see a broad range of patients, including those with uncommon immunodeficient states.

Your clinical training at this site will give you insights into an active program of clinical trials in cancer treatment. You’ll learn about host defense pathways and the spectrum of opportunistic infections observed in patients with immune deficiencies resulting from cancer and chemotherapy.

You’ll gain experience diagnosing and managing patients with a diverse spectrum of infections, including opportunistic fungal and viral diseases, and patients with bone marrow transplants in the setting of neutropenia and graft-versus-host disease.

Rotation

Roswell Park Comprehensive Cancer Center website

Location

Patient Population

  • hematology-oncology patients
  • immunocompromised patients (with prolonged neutropenia or receiving intensive immunosuppressive regimens)
  • patients with primary immunodeficiencies (e.g., chronic granulomatous disease)
  • bone marrow transplant recipients

Faculty and Staff

  • three full-time divisional faculty